Xilio Therapeutics, Inc.XLONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR-1.0%
5Y CAGR+24.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-1.0%/yr
Annual compound
5Y CAGR
+24.8%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $29.05M | +17.2% |
| 2024 | $24.78M | -8.2% |
| 2023 | $27.00M | -9.9% |
| 2022 | $29.95M | +34.0% |
| 2021 | $22.36M | +133.2% |
| 2020 | $9.59M | +111.6% |
| 2019 | $4.53M | - |